Verona Pharma Plc ADR (VRNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | VRNA | KRYS | IBRX | ||
| Company | Verona Pharma Plc ADR | Krystal Biotech Inc | Immunitybio Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 106.85 | 309.53 | 8.01 | ||
| High | 106.93 | 317.21 | 8.34 | ||
| Low | 106.81 | 302.87 | 7.78 | ||
| Latest | 106.91 | 312.58 | 8.15 | ||
| Change | +0.12 | +2.27 | +0.03 | ||
| % Change | +0.11% | +0.73% | +0.37% | ||
| Volume | 1,871,900 | 320,100 | 10,542,899 | ||
| 20-Day Average Volume | 1,504,320 | 310,385 | 13,153,660 | ||
| Previous Close | 106.79 | 310.31 | 8.12 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 106.48 | 281.64 | 7.72 | ||
| 20-Day Raw Stochastic | 98.26% | 92.90% | 72.45% | ||
| 20-Day Relative Strength | 70.52 | 68.34 | 53.59 | ||
| Weighted Alpha | +201.62 | +140.01 | +28.85 | ||
| Today's Opinion | 100% Buy | 88% Buy | 88% Buy | ||
| Previous Opinion | 100% Buy | 88% Buy | 88% Buy | ||
| Last Month's Opinion | 100% Buy | 80% Buy | 40% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.28% since 09/29/25 | +8.16% since 05/06/26 | -2.74% since 05/06/26 | ||
| Low | 106.61 on 09/30/25 | 279.74 on 05/07/26 | 7.36 on 05/07/26 | ||
| High | 106.93 on 10/06/25 | 317.21 on 05/13/26 | 8.69 on 05/11/26 | ||
| 1-Month | |||||
| %Chg | +0.56% since 09/05/25 | +16.89% since 04/13/26 | +11.64% since 04/13/26 | ||
| Low | 105.78 on 09/19/25 | 251.97 on 05/04/26 | 6.73 on 04/29/26 | ||
| High | 106.93 on 10/06/25 | 317.21 on 05/13/26 | 8.69 on 05/11/26 | ||
| 3-Month | |||||
| %Chg | +16.80% since 07/03/25 | +13.07% since 02/13/26 | +37.09% since 02/13/26 | ||
| Low | 86.63 on 07/08/25 | 242.00 on 03/31/26 | 5.93 on 02/17/26 | ||
| High | 106.93 on 10/06/25 | 317.21 on 05/13/26 | 12.43 on 02/25/26 | ||
| 6-Month | |||||
| %Chg | +98.35% since 04/04/25 | +55.35% since 11/13/25 | +307.50% since 11/13/25 | ||
| Low | 47.20 on 04/07/25 | 198.02 on 11/14/25 | 1.95 on 12/31/25 | ||
| High | 106.93 on 10/06/25 | 317.21 on 05/13/26 | 12.43 on 02/25/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 8,748,446 | 9,147,936 | 8,504,514 | ||
| Shares Outstanding, K | 81,830 | 29,480 | 1,047,354 | ||
| Annual Sales | 42,280,000 | 389,130,000 | 113,290,000 | ||
| Annual Net Income | -173,420,000 | 204,830,000 | -351,400,000 | ||
| Last Quarter Sales | 103,140,000 | 116,360,000 | 44,210,000 | ||
| Last Quarter Net Income | 11,920,000 | 55,930,000 | -632,780,000 | ||
| 60-Month Beta | 0.05 | 0.50 | 0.02 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.13 on 08/06/25 | 1.83 on 05/04/26 | -0.09 on 05/07/26 | ||
| Earnings Date | 11/03/25 | 08/03/26 | 08/04/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 41.83 | 0.00 | ||